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Vascular smooth muscle cells (VSMCs) proliferation and migration, which are central in the development of vascular
diseases, are regulated by numerous hormones and humoral factors. Activation of the insulin receptor stimulates VSMCs
proliferation while dopamine receptors, via D1 and D3 receptors, inhibit the stimulatory effects of norepinephrine on
VSMCs proliferation. We hypothesize that activation of the D4 dopamine receptor may also inhibit the proliferation and
migration of VSMCs, therefore, inhibit atherosclerosis. Our current study found that insulin increased the proliferation and
migration of A10 cells, an effect that was reduced in the presence of a D4 receptor agonist, PD168077. The negative
effect of the D4 receptor on insulin’s action may be via decreasing insulin receptor expression, because activation
of the D4 receptor inhibited insulin receptor protein and mRNA expressions, indicating that the regulation occured
at the transcriptional or post-transcriptional levels. To determine whether or not the inhibition of D4 receptor on
insulin-mediated proliferation and migration of VSMCs has physiological significance, hyper-insulinemic Sprague–Dawley
rats with balloon-injured carotid artery were treated with a D4 agonist, PD168077, (6 mg/kg/d) for 14 days. We found
that PD168077 significantly inhibited neointimal formation by inhibition of VSMC proliferation. This study suggests that
activation of the D4 receptor suppresses the proliferation and migration of VSMCs, therefore, inhibit atherosclerosis. The
D4 receptor may be a potential therapeutic target to reduce the effects of insulin on artery remodeling.
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The abnormal proliferation and migration of vascular
smooth muscle cells (VSMCs) play a crucial role in neoin-
timal formation and vascular remodeling during athero-
sclerosis and restenosis [1-3]. It is currently accepted that
proliferation and migration of medial VSMCs are involved
in neointimal formation after injury, which could be in-
duced by cytokines and growth factors, including insulin.
Insulin initiates many biological effects by activating the
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unless otherwise stated.protein kinase, triggering hypertrophy, proliferation, and
migration of VSMCs [4-6]. Therefore, inhibition of insulin-
mediated VSMCs proliferation and migration would be
helpful in preventing the development of atherosclerosis
and restenosis after angioplasty.
Dopamine receptors exert beneficial effects by regulating
epithelial sodium transport and vascular smooth muscle
tone in hypertension [7-12]. Dopamine receptors are
classified into D1-like and D2-like subtypes based on
their structure and pharmacology. D1-like receptors are
composed of D1 and D5 receptors while D2-like receptors
are composed of D2, D3 and D4 receptors [6-11]. We have
previously shown that activation of D1-like or D3 receptor
inhibits the insulin-mediated VSMCs proliferation [13,14].
Activation of D1-like and D3 receptors has an additive in-
hibitory effect on norepinephrine-mediated proliferationThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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also have inhibitory effect on insulin-mediated VSMCs
proliferation and migration, which may inhibit the forma-
tion of atherosclerosis. To test this hypothesis, we used cul-
tured rat aortic smooth muscle cells line (A10) to examine
the potential effect of D4 receptors on insulin-mediated
proliferation and migration, and investigated the role of D4
receptors on neointimal hyperplasia in Sprague–Dawley
(SD) rats with hyperinsulinemia.
Methods
Materials
PD168077 (D4 receptor agonist), L745870 (D4 receptor
antagonist), streptozotocin (STZ) were from Sigma Co.
(Sigma, St. Louis, MO). Insulin was purchased from
Roche Group (Basel, Switzerland); Rabbit polyclonal
antibody against insulin receptor, cleaved caspase 3 and
Histone H3 were from Cell Signaling (Beverly, MA). Anti-
body for proliferating cell nuclear antigen (PCNA) was
from Santa Cruz. SDS-polyacrylamide gels were from
Pierce (Rockford, IL). Polyvinylidene fluoride (PVDF) and
protein gel apparatus were from Bio-Rad (Hercules, CA).
Minimal essential medium (MEM), Dulbecco’s modified
Eagle’s medium (DMEM), and fetal bovine serum (FBS)
were from Gibco/Invitrogen (Carlsbad, CA); fibroblast
growth factor (FGF), epidermal growth factor (EGF),
phosphate buffered saline (PBS), penicillin/streptomycin,
and non-essential amino acids were from Sigma Co.
Cell culture
A10 cell [13], a smooth muscle cell line from rat thoracic
aorta, was purchased from ATCC (A10; ATCC, Hercules,
CA), and cultured in DMEM supplemented with 20% FBS
and 1% penicillin/streptomycin/bFGF/EGF at 37°C in a
humidified, 5% CO2 atmosphere. After reaching sub-
confluence, the A10 cells were serum-starved for 24 hrs
in serum-free DMEM to maintain quiescence before
further treatment.
A10 cell proliferation
Cell proliferation was determined by measuring the up-
take of tetrazolium salt, 3-(4,5-dimethylthiazol-2-yl)-2,5di-
phenyltetrazolium bromide (MTT) and the incorporation
of [3H]-thymidine (Atomic Energy Research Establishment
of China, Beijing City, China) into DNA of cells respect-
ively. The cells were seeded into 96-well (100 μl of medium
per well) culture plates at a density of 1 × 104 cells/well,
made quiescent for 24 hrs, and then stimulated with the in-
dicated reagents. Subsequently, 20 μl of MTT (5 mg/ml)
were added to each well, and the incubation continued for
an additional 4 hrs at 37°C. Thereafter, dimethyl sulfoxide
(DMSO, 150 μl) was added to each well, and absorbance
read at 490 nm on a Microplate reader (model 680, Bio-
Rad). For [3H]-thymidine incorporation assay, the cellswere treated with the same reagents then labeled with [3H]-
thymidine (1 μCi/ml) 6 h and assessed for [3H] incorpor-
ation into newly synthesized DNA as previously described
[13]. Cell number was also used to estimate cell prolifera-
tion by plating the A10 cells in six-well plastic culture
dishes at a density of 1 × 104/well in DMEM with 10% FBS.
The medium was then removed and washed three times
with PBS. The cells were incubated in serum-free medium,
which contained the indicated reagents for the indicated
times. After incubation, the number of cells was counted by
a hemocytometer (trypan blue uptake, which indicates cell
death, was observed in <10% of the cells). Experiments
were performed independently at least three times [13-15].
A10 cell migration
Cells migration was examined using transwell and
scratch-wound migration assays. The transwell migration
assay was performed using 24-well tissue culture plates
(BD Bioscience, Becton, NJ) with an 8-μm-pore polycar-
bonate membrane [16,17]. The number of migratory A10
cells was counted in 10 randomly chosen fields of dupli-
cate chambers at a magnification of 200× for each sample.
For the scratch-wound migration assay, the A10 cells were
scratched with a small tip along the ruler. After washing,
the cells were cultured in serum-free DMEM for 48 hrs.
The migration area (%) was analyzed in 10 randomly
chosen fields under an inverted microscope (IX-70;
Olympus, Tokyo, Japan), using NIH Image J software; area
at 0 hr and area at 48 hrs × 100% was calculated.
Immunoflurescence image of rat thoracic aorta
Expression of D4 receptors in thoracic aorta from SD rats
was examined by laser scanning confocal microscope.
Briefly, the aorta was cleared of blood with ice-cold oxy-
genated saline and kept in Histochoice (Amresco, Solon,
OH) for one to two days at 4°C, then sectioned (4 μm),
embedded in paraffin, and mounted on slides. The sections
were double-immunostained with mouse anti-D4 receptor
antibody (1:100) and rabbit polyclonal anti-α-SM-actin
antibody (1:100). The colocalization of D4 receptors and
α-SM-actin was performed as described previously [18].
Immunoblotting
A10 cells were treated with vehicle (ddH2O), D4 recep-
tor agonist (PD168077) and/or D4 receptor antagonist
(L745870) at the indicated concentrations and times.
After treatment, the A10 cells were washed once in PBS
and lysed in lysis buffer. Immunoblotting was performed
as previously reported [13,14]. Protein concentration was
determined using a protein assay kit (Bio-Rad Laboratories,
Hercules, CA) with bovine serum albumin as standard. Cell
lysates were boiled in sample buffer (35 mmol/L Tris–HCl,
pH 6.8, 4% SDS, 9.3% dithiothreitol, 0.01% bromophenol
blue, 30% glycerol) for 10 min; 50 μg of cell protein were
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were blocked with 5% nonfat dry milk in PBS-T [0.05%
Tween20 in 10 mmol/L phosphate-buffered (isotonic)
saline] at 37°C for 2 hrs with constant shaking. The
membranes were then probed with rabbit polyclonal
antibodies specific for insulin receptor and D4 receptor at
4°C overnight, and then incubated with goat anti-rabbit
polyclonal antibodies conjugated to horseradish peroxidase.
Proteins were detected using enhanced chemiluminescence
reagents (Amersham, Little Chalfont, UK). The amount of
protein transferred onto the membranes was normalized by
immunoblotting of α-actin (monoclonal α-actin antibody,
1:400, Santa Cruz Biotechnology, Inc. Santa Cruz, CA).
Reverse transcriptase-PCR
Total RNA from A10 cells was isolated using a Trizol
procedure (Invitrogen, Carlsbuel, CA). Two μg of totalA -SM-actin
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Figure 1 Expression of D4 receptors in rat thoracic aorta and A10 cell
microscopy in thoracic aorta from SD rats. The arteries were washed, fixed,
as described in the Methods. Colocalization appears as yellow after mergin
and Alexa 568-tagged α-SM-actin (green). B: D4 receptor protein expression w
the expression of D4 receptor protein (lane1 and lane2) in A10 cells and rat th
pre-adsorbed by the immunizing peptide (1/10 w/w, lane3 and lane4). C. D4
indicated the expression of D4 receptor mRNA in A10 cells and in rat thoracic
absence of template (lane1) or primers (lane2).RNA were used to synthesize cDNA, which served as
template for the amplification of D4 receptor, insulin
receptor, and β-actin (as housekeeping gene). Primer
sequences for D4 receptor were 5
′-TGC CCT GTC CGC
TCA TGC TAC TGC-3′ (forward) and 5′-CAC CGG
CAG GAC TCT CAT CGC CTT GC-3′ (reverse). Primer
sequences for insulin receptor were 5′-GGA CTGAAG
GTA TGA ATG GAG-3′ (forward) and 5′-TAA CAC
AAG CCA AGG AAG GG-3′ (reverse), Primer sequences
for β-actin was 5′-GTGGGTATGGGTCAGAAGGA-3′
(forward) and 5′-AGCGCGTAACCCTCATAGAT-3′ (re-
verse). The amplification was performed with the following
conditions: 95°C for 1 min, followed by 35 cycles of de-
naturation at 94°C for 30 sec, annealing at 60°C for 30 sec,
and extension at 72°C for 45 sec. This was followed by a
final extension at 72°C for 10 min. The PCR products
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s. A: D4 receptor protein expression was determined by confocal
and immunostained for D4 receptor and α-smooth muscle (SM)-actin
g the images of fluorescein isothiocyanate-tagged D4 receptor (red)
as determined in artery by immunoblotting. The 47 kDa band indicated
oracic aorta because it was no longer visible when the antibodies were
receptor mRNA expression was determined by RT-PCR. The 367 bp band
aorta (lane3 and lane4) because the band was not observed in the
Figure 2 (See legend on next page.)
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Figure 2 Effect of D4 receptor on insulin-mediated proliferation in A10 cells. A. Effect of insulin on the proliferation of A10 cells. A10 cell
proliferation was determined by the uptake of the tetrazolium salt, 3-(4,5-dimethylthiazol-2-yl)-2,5 diphenyltetrazolium bromide (MTT) after incubation
with different concentrations of insulin. Results are expressed as MTT optical density (n = 10, *P < 0.05 vs. control, one-way ANOVA, Holm-Sidak test).
Control cells were treated with vehicle. B. Effect of D4 receptor agonist on the proliferation of A10 cells. A10 cell proliferation was determined by MTT
after incubation with the indicated concentrations of the D4 receptor agonist PD168077 (10
−10 mol/L~10−6 mol/L). Results are expressed as MTT optical
density (n = 10, P = NS, one-way ANOVA, Holm-Sidak test). Control cells were treated with vehicle. C and D. Effect of D4 receptor on insulin-mediated
proliferation in A10 cells. A10 cell proliferation was determined by MTT (C) or number of cells (D) after incubation with insulin (10−7 mol/L) in the
absence or presence of varying concentrations of the D4 receptor agonist, PD168077 (PD, 10
−11 mol/L - 10−6 mol/L). Results are expressed as MTT
optical density or cell number/well (n = 8-9, *P < 0.05 vs. control; #P < 0.05 vs. insulin alone). E-G. The specificity of D4 receptor action on proliferation
of A10 cells. A10 cells were incubated with vehicle (control), insulin 10−7 mol/L alone or in the presence of the D4 receptor agonist, (PD,
PD168077, 10−7 mol/L) (insulin + PD) or both D4 receptor agonist (PD) and D4 receptor antagonist (L, L745870, 10
−7 mol/L) (insulin + PD + L) for
24 hours. A10 cell proliferation was determined by MTT (E) or [3H]-thymidine incorporation (F) and number of cells (G). Results are expressed as MTT
optical density (n = 8) or cpm/mg protein (n = 4) 0r cell number/well (n = 9; *P < 0.05 vs. control; #P < 0.05 vs. insulin alone).
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Healthy male SD rats weighing 210-220 g, were obtained
from the Experimental Animal Center of Daping Hos-
pital. The rats were housed on a constant 12 hrs light/
12 hrs dark cycle in temperature-controlled central facil-
ity (18-22°C) and allowed free access to normal chow
and tap water. Type 2 diabetes was induced using STZ,
as described previously [19,20]. Briefly, the rats were
intragastrically fed high-fat diet (HFD) consisting of 15%
lard, 30% sucrose, 10% Tween-80 and 10% propylene
glycol in a volume of 20 ml/kg body weight once a day
for 4 weeks (normal-pellet diet rats served as the con-
trol). Then the rats were injected intraperitoneally with
STZ (25 mg/kg in a 0.1 mol/L citrate buffer at a single
dose, pH 4.5) to induce type 2 diabetes with hyperinsuli-
nemia and insulin resistance. After STZ injection, body
mass and blood pressure were measured; blood samples
were obtained from the tail vein for assay of blood glu-
cose, serum insulin, triglycerides, cholesterol, and free
fatty acids using commercially available kits. The rats
with fasting blood glucose concentrations more than
11.1 mmol/L were considered to qualify for subsequent
experiments.
Rat carotid balloon injury
SD rats were anesthetized using a mixture of ketamine
(80 mg/kg) and xylazine (12 mg/kg), and then the left
common and external carotid arteries were exposed and
isolated. A 2 F Fogarty catheter (Edwards Life Sciences,
Irvine, CA) was introduced into the common carotid ar-
tery through an arteriotomy in the external carotid ar-
tery and inflated to 1.0-1.5 atm. A 10-mm injury was
induced by withdrawing the catheter 4 times. The exter-
nal carotid artery was then untied, and blood flow was
restored. After the balloon-injury, SD rats were intraper-
itoneally injected with PD168077 (6 mg/kg per day) or
similar volume of distilled water (2 ml/kg) daily for
14 days. Before the SD rats were euthanized, body mass
and blood pressure were measured, and bloods for bio-
chemical parameter measurements were obtained. Then,both carotid arteries were dissected and the sections
were stained with hematoxylin and eosin (H&E) and ob-
served under a light microscope (Olympus, Tokyo,
Japan). Media and neointima areas of injured arteries
were quantified by planimetry (μm2) and intima-to-
media ratios were calculated as reported [21,22].
Proliferation and apoptosis of rat carotid arteries treated
with PD168077 after balloon injury
Cell proliferation and apoptosis are important contribu-
tors to neointimal formation after balloon injury. We
performed experiments investigating the role of
PD168077 in reducing the proliferation and sustaining
the apoptosis of rat carotid artery at day14 after balloon
injury. PCNA (1:500) and cleaved caspase 3 (1:800) ex-
pression were evaluated the proliferation or apoptosis
respectively by western-blot as previously.
Statistical analysis
The data are expressed as mean ± SEM. Comparison
within groups was made by repeated measures ANOVA
(or paired t−test when only 2 groups were compared),
and comparison among groups (or t-test when only 2
groups were compared) was made by factorial ANOVA
with Holm-Sidak test. A value of P < 0.05 was considered
significant.
Results
D4 receptor in artery
D4 receptor expression in rat thoracic aorta was deter-
mined by double-immunostaining, immunoblotting, and
RT-PCR analysis. The D4 receptor is expressed in the
vascular smooth muscle, proved by its colocalization
with α-SM-actin (Figure 1A). Immunoblotting revealed
that a 47 kDa band, expected molecular size for the D4
receptor protein, disappeared when the antibody was
pre-adsorbed with the corresponding immunizing pep-
tide (1/10 w/w) (Figure 1B). RT-PCR for the D4 receptor
in rat thoracic aorta and A10 cells showed the expected
D4 receptor size of 367 bp (Figure 1C).
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A10 cell proliferation and migration
VSMCs are the main cellular components of neointimal
lesions after vascular injury. Their migration and pro-
liferation contribute to the formation of these lesions.
Therefore, the effect of D4 receptor on A10 cell prolifer-
ation was explored by using MTT, [3H]-thymidine in-
corporation and direct cell counting. Insulin increased
A10 cell proliferation in a concentration-dependent
manner in A10 cells (Figure 2A). Although PD168077
by itself had no effect on cell proliferation (Figure 2B), it
inhibited the insulin-mediated proliferation in A10 cellsFigure 3 Effect of D4 receptor on insulin-mediated A10 cell migra
insulin-mediated A10 cell migration. A10 cell migration was determine
incubation with insulin (10−7 mol/L), alone, or in the presence of varyi
Results are expressed as migratory cell number or migration distance
Specificity of D4 receptor action on insulin-mediated migration of A10
10−7 mol/L alone or in the presence of the D4 receptor agonist, (PD, P
(PD) and D4 receptor antagonist (L, L745870, 10
−7 mol/L) (insulin + PD
scratch-wound migration assay (D). Results are expressed as migratory
#P < 0.05 vs. insulin alone).in a concentration-dependent manner (10−8-10−6 mol/L)
(Figure 2C and D). The inhibitory effect of D4 receptor
was specific because the D4 receptor antagonist L745870
(10−7 mol/L/24 hrs) blocked the cell proliferative effect of
PD168077 (Figure 2E, F and G).
We also studied the effect of insulin on cell migration
by transwell and scratch-wound migration tests. Insulin
increased the migration of A10 cells, an effect that was
inhibited by a D4 receptor agonist, PD168077, in a
concentration-dependent manner (Figure 3A and B).
Consistent with the cell proliferation study, the inhibi-
tory effect of PD168077 was specific to the D4 receptortion. A and B. Effect of the D4 receptor agonist PD168077 on
d by transwell (A) and scratch-wound migration assay (B) after
ng concentrations of PD168077 (PD, 10−10 mol/ - 10−6 mol/L).
(n = 9, *P < 0.05 vs. control; #P < 0.05 vs. insulin alone). C and D.
cells. A10 cells were incubated with vehicle (control), insulin
D168077, 10−7 mol/L) (insulin + PD) or both D4 receptor agonist
+ L). A10 cell migration was determined by transwell (C) and
cell number or migration distance (n = 9, *P < 0.05 vs. control;
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−7 mol/
L/24 hrs) blocked the effect of PD168077 on cell migration
(Figure 3C and D).
Activation of D4 receptor decreases insulin receptor
expression in A10 cells
To uncover the mechanisms underlying the negative
regulation of the D4 receptor of insulin-mediated pro-
liferation and migration in A10 cells, we quantified the
expression of insulin receptor. We found that stimulation
of the D4 receptor by a D4 receptor agonist, PD168077,
decreased insulin receptor expression in a concentration
(10−10 -10−6 mol/L) and time (4-30 hrs)-dependent man-
ner (Figure 4A and B). The effect of PD168077 on insulin
receptor expression was via the D4 receptor, because a D4Figure 4 Effect of D4 receptor on insulin receptor expression in A10 c
PD168077 on insulin receptor protein expression in A10 cells. A10 cells were in
of the D4 receptor agonist PD168077 (PD, 10
−10 mol/L - 10−6 mol/L) for 24 hrs.
water (dH2O), instead of insulin, was used as control. Results are expressed as t
B. Time-course of the effect of the D4 receptor agonist PD168077 on insulin r
indicated times with PD168077 (PD, 10−7 mol/L). dH2O, instead of insulin, was
α-actin densities (n = 5, *P < 0.05 vs. control). C and D. Specificity of D4 recept
incubated with the indicated reagents: (dH2O [Control], PD, PD168077, 10
−7 m
protein or mRNA expressions were determined by immunoblotting (C) or RT-
of 100%) to α-actin for immunoblotting or β-actin densities for RT-PCR (as a frreceptor antagonist, L745870 (10−7 mol/L/24 hrs), blocked
the inhibitory effect of PD168077 on insulin receptor
expression in A10 cells (Figure 4C). Stimulation of the
D4 receptor PD168077 (10
−7 mol/L/24 hrs) also de-
creased insulin receptor mRNA expression, an effect
that was blocked by the D4 receptor antagonist L745870
(Figure 4D), suggesting that the regulation of insulin re-
ceptor by the D4 receptor occurs at the transcriptional
or post-transcriptional levels.
Effect of D4 receptor on neointima formation in
balloon-injured carotid arteries of SD rats
To determine whether or not the D4 receptor-mediated
inhibition of insulin-induced proliferation and migration
of A10 cells had physiological significance, we studiedells. A. Concentration-dependent effect of the D4 receptor agonist
cubated with insulin in the absence or presence of varying concentrations
Insulin receptor expression was determined by immunoblotting. Distilled
he ratio of insulin receptor to α-actin densities (n = 5, *P< 0.05 vs. control).
eceptor protein expression in A10 cells. The cells were incubated at the
used as control. Results are expressed as the ratio of insulin receptor to
or effect on insulin receptor expression in A10 cells. A10 cells were
ol/L, L,L745870, 10−7 mol/, or PD + L) for 24 hrs. The insulin receptor
PCR (D). Results are expressed as the ratio of insulin receptor (as a fraction
action of 100%) individually (n = 5, *P < 0.05 vs. others).
Table 1 Metabolic characteristics and biochemical parameter in SD rats induced using high-fat feeding in combination
with STZ and PD168077
NPD HFD HFD±STZ HFD±STZ+PD168077
Bodyweight (g) 302±7.8 344±12.8* 346±10.51* 342±10.77*
Mean blood pressure (mmHg) 60.74± 7.92 6 1.20± 8.85 64.05 ± 8.70 59.85 ±9.45
Blood glucose (mmol/L) 4.35 ±0.47 5.22 ±0.26 12.76±0.88*# 11.3 1±0.75*#
Serum insulin (pmol/L) 22.37± 7.44 68.23 ± 3.26* 77.25 ±3.87* 78.46±3.61*
Triglycerides (mmol/L) 1.33±0.39 1.98±0.11* 2.15±0.11* 2.03±0.15*
Total cholesterol (mmol/L) 2.88 ±0.47 4.55 ±0.22* 4.68±0.37* 4.69±0.35*
Free fatty acids (mmol/L) 0.26± 0.12 0.56±0.02* 0.58±0.06* 0.64±0.05*
*P < 0.05 versus NPD 7 weeks; #P < 0.05 versus HFD; NPD: nomal-pellet diet; HFD: high-fat diet; STZ: streptozotocin; PD168077: D4 receptor agonist; n = 6.
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sulinemic type 2 diabetic SD rats (Table 1). A significant
increase in the body weight was observed in the rats fed
with HFD compared to rats fed with normal pellet diet
(NPD). Before STZ injection, HFD-fed rats had similarFigure 5 Effect of PD168077 on neointimal formation after vascular in
were intraperitoneally injected with vehicle or PD168077 (6 mg/kg/day) for
graphs. A: sham operation control. B: balloon-injured carotid artery and veh
The bar graphs show the area of the intima to media ratio (I/M ratio, D) (n
vehicle group).glucose concentrations to NPD-fed rats, but significantly
higher serum insulin, triglyceride, total cholesterol,
and free fatty acids concentrations, Injection of STZ
(25 mg kg−1), The level of blood glucose significantly
increased compared to HFD-fed rats and NPD-fed rats,jury in SD rats with hyperinsulinemia. Carotid balloon-injured rats
14 days. Representative histologies (A-C) were shown above the bar
icle injection. C: balloon-injured carotid artery and PD168077 injection.
= 6, *P < 0.05 vs. sham group, #P < 0.05 vs. balloon-injured and
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resistance. However, the blood pressure remained un-
altered among STZ + HFD-treated rats, HFD-treated
rats and control NPD-fed rats. We found no significant
changes in each parameter between PD168077-treated
and untreated STZ +HFD rats. The carotid artery-injured
rats were then intraperitoneally injected with PD168077
(6 mg/kg/d) for 14 days to investigate the role of
PD168077 in neointimal formation in vivo. Consistent
with previous reports [21,23], a significant increase in
neointimal formation was found 2 weeks after the bal-
loon injury of the carotid artery (Figure 5A and B).
Compared with balloon injury and vehicle-injected group,
PD168077 significantly inhibited neointimal formation, as-
sociated with a decrease in the intima/media (I/M) ratio
(Figure 5C and D).Effect of D4 receptor on proliferation and apoptosis of in
balloon-injured carotid arteries of SD rats
PCNA expression revealed a significant decrease in pro-
liferation in the PD168077-injected rats compared with
vehicle-injected rats (Figure 6A). There was no difference
in cleaved caspase 3 expression between two groups
(Figure 6B), it seemed likely that the mechanisms of
PD168077 inhibited neointimal hyperplasia were attrib-
uted to its antiproliferative and not apoptotic effects in
balloon injured carotid artery of STZ + HFD rats.Figure 6 Effects of PD168077 on the proliferation and apoptosis
of balloon-injured carotid in SD rats with hyperinsulinemia.
Carotid balloon-injured rats were intraperitoneally injected with
vehicle or PD168077 (6 mg/kg/day) for 14 days. Proliferation was
measured by immunoblotting of proliferating cell nuclear antigen
(PCNA) (A) and cleaved caspase 3 expression (B) in PD168077-treated
and control rats. Results are expressed as the ratio of PCNA to Histone
H3 densities or ratio of caspase-3 to α-actin densities (n = 4, *P < 0.05
vs. control).Discussion
Insulin resistance and hyperinsulinemia are important
risk factors for cardiovascular disease due, in part, to the
VSM proliferative and pro-atherogenic actions of insulin
[3,5,24,25]. Therefore, reducing the stimulatory effect of
insulin on VSMC proliferation and migration may pro-
vide new insights in the prevention of atherosclerosis.
More and more pieces of evidence indicate an inter-
action between insulin and dopamine receptors in vari-
ous tissues and cells. The renal dopaminergic system is
impaired in hyperinsulinemic rats and type 2 diabetes
patients [26-28]. The dopamine D1-like receptor agonist,
fenoldopam, has been shown to improve peripheral insu-
lin sensitivity in STZ-induced type 2 diabetic rats [29]. In
pancreatic beta cells, the D2-like receptor (D2R/D3R)
agonist quinpirole inhibits glucose-stimulated insulin se-
cretion [30]. Another D2-like receptors agonist, bromo-
criptine, has been reported to decrease insulin levels of
obese women [31]. Our previous studies also indicate a
negative interaction between D1-like and insulin receptors
because a D1-like receptor agonist, fenoldopam, inhibits
the proliferative effect of insulin in A10 cells [13]. Stimula-
tion of the D3 receptor also inhibits insulin receptor
mRNA and protein expressions and insulin-mediated
VSMC proliferation [14]. However, whether or not the D4receptor has inhibitory effect on insulin-mediated VSMC
proliferation and migration is unknown.
Previous studies have demonstrated that D4 receptors
are expressed in the adventitia and adventitia-media
border of human pulmonary and coronary arteries
[32,33]. We now show, for the first time, that D4 receptors
are expressed in thoracic aorta of SD rats, determined
RT-PCR and immunoblotting and in VSM of the aorta,
by double-immunofluorescence staining. Moreover, the
D4 receptor in VSMCs is functional. Stimulation of the D4
receptor reduced insulin-mediated VSMC proliferation
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effect.
The importance of the D4 receptor on VSMC remod-
eling during insulin resistance was investigated using a
rat model of insulin resistance and hyperinsulinemia
(STZ-treated rats on high fat diet). Treatment of these
rats with PD168077, a D4 receptor agonist, for two weeks
prevented neointimal growth in balloon-injured carotid
artery. Neointimal formation after vessel injury is a com-
plex process involving the proliferation and migration of
VSMCs [21]. Apoptosis is also important in this process
[34,35]. In this study, PD168077 significantly reduced the
balloon injury caused neointimal hyperplasia in rat carotid
artery. PCNA expression was also decreased in injured ar-
tery with PD168077 treatment. However, the expression
of cleaved caspase 3 was not significant change in injured
carotid arteries between the two groups which seems pro-
liferation not apoptosis likely to be the major contributor
for attenuation of neointimal formation after treatment
with PD168077. Based on these findings and previous
studies, we speculate that the D4 receptor may be a target
to inhibit abnormal VSMC growth induced by insulin,
which may lead to a novel strategy in the treatment of
atherosclerosis.
In summary, we have demonstrated that activation of
the D4 receptor inhibits insulin receptor expression and
insulin-mediated proliferation and migration of A10 cells
in vitro, and neointimal formation in vivo. This study
implicates a critical role of the D4 receptor in the patho-
genesis of vascular remodeling and this new insight may
result in the development of a novel strategy in the
treatment and prevention of vascular injury associated
with insulin resistance.
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